This company has been marked as potentially delisted and may not be actively trading. IMMURON (IMRN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IMRN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Immuron enters partnership with InvestorHubAugust 27, 2025 | msn.comImmuron partners with InvestorHubAugust 26, 2025 | globenewswire.comImmuron CEO to Present at Emerging Growth ConferenceAugust 13, 2025 | msn.comImmuron Stock Short Interest Report | NASDAQ:IMRN - BenzingaJuly 18, 2025 | benzinga.comImmuron Stock (NASDAQ:IMRN), Insider Trading ActivityJuly 18, 2025 | benzinga.comHealth Check: Immuron shares bust out for a ‘run’ on strong Travelan salesJuly 18, 2025 | msn.comImmuron - FY25 global sales exceed projection, up 49% on prior yearJuly 17, 2025 | globenewswire.comImmuron Limited American Depositary Shares (IMRN)June 10, 2025 | nasdaq.comImmuron Limited Issues New Shares in Compliance with Corporations ActJune 3, 2025 | tipranks.comImmuron Limited Reports Strong Sales Projections and Updates on Clinical Trials and Product LaunchesMay 30, 2025 | quiverquant.comQImmuron Letter to Shareholders: Projects UpdateMay 30, 2025 | globenewswire.comImmuron Limited Poised for Record Sales and Clinical AdvancementsMay 29, 2025 | tipranks.comImmuron Limited Issues New Shares in Compliance with Corporations ActMay 29, 2025 | tipranks.comCitizens JMP Slashes Prothena (PRTA) to $29 from $78 After AFFIRM-AL Trial FailsMay 29, 2025 | msn.comImmuron Limited Announces Proposed Securities IssueMay 29, 2025 | tipranks.comIs Immuron Limited (IMRN) the Best Australian Stock to Buy According to Analysts?May 15, 2025 | msn.comImmuron reports record Travelan salesApril 12, 2025 | uk.investing.comImmuron Limited Announces New Share IssuanceApril 11, 2025 | tipranks.comImmuron Limited Announces New Securities IssuanceApril 11, 2025 | tipranks.comImmuron Limited Announces Cessation of Performance RightsApril 11, 2025 | tipranks.comImmuron Travelan® highest sales in historyApril 10, 2025 | globenewswire.comImmuron Limited Achieves Record Sales with Travelan®April 9, 2025 | tipranks.comImmuron partners with Calmino to distribute ProIBS in Australia, New ZealandMarch 6, 2025 | markets.businessinsider.comImmuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)March 5, 2025 | globenewswire.comImmuron Partners with Calmino to Launch IBS Treatment in Australia and New ZealandMarch 4, 2025 | tipranks.comImmuron Limited Sponsored ADRJanuary 17, 2025 | cnn.comImmuron reports strong sales growth of TravelanJanuary 17, 2025 | markets.businessinsider.comImmuron reports strong sales growth for TravelanJanuary 17, 2025 | msn.comImmuron Travelan® continued strong sales growthJanuary 17, 2025 | globenewswire.comImmuron Limited Issues New Ordinary Shares Complying with Legal StandardsJanuary 16, 2025 | tipranks.comImmuron Limited Applies for Quotation of New SecuritiesJanuary 16, 2025 | tipranks.comImmuron announces research collaboration agreement with Monash UniversityJanuary 15, 2025 | markets.businessinsider.comImmuron Announces New Research Collaboration targeting Antimicrobial ResistanceJanuary 15, 2025 | globenewswire.comImmuron Limited Announces Proposed Issue of SecuritiesJanuary 14, 2025 | tipranks.comImmuron announces Travelan clinical trial updateJanuary 14, 2025 | markets.businessinsider.comImmuron Partners with Monash University to Combat Antimicrobial ResistanceJanuary 14, 2025 | tipranks.comImmuron Announces Travelan® Clinical Trial UpdateJanuary 14, 2025 | globenewswire.comImmuron progresses development of traveller's diarrhea drug TravelanJanuary 14, 2025 | msn.comImmuron Submits Positive Travelan® Phase 2 Study Results to FDAJanuary 13, 2025 | tipranks.comImmuron Limited Quotation of New Securities on ASXJanuary 9, 2025 | tipranks.comImmuron Limited Announces Proposed Securities IssueJanuary 7, 2025 | tipranks.comImmuron Limited Issues New Unquoted Equity SecuritiesDecember 9, 2024 | tipranks.comImmuron Limited Director Acquires 1,000,000 OptionsDecember 9, 2024 | tipranks.comImmuron Limited Director Increases Stake with New OptionsDecember 9, 2024 | tipranks.comImmuron Limited Director Acquires Unlisted OptionsDecember 9, 2024 | tipranks.comImmuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thDecember 2, 2024 | globenewswire.comImmuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNovember 22, 2024 | finance.yahoo.comImmuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNovember 21, 2024 | globenewswire.comImmuron Limited Secures Approval on Key AGM ResolutionsNovember 18, 2024 | markets.businessinsider.comImmuron Limited Issues New Unquoted Performance RightsOctober 29, 2024 | markets.businessinsider.com Get IMMURON News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMRN Media Mentions By Week IMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMRN News Sentiment▼0.000.96▲Average Medical News Sentiment IMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMRN Articles This Week▼11▲IMRN Articles Average Week Get the Latest News and Ratings for IMRN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for IMMURON and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies JSPR News Today STTK News Today ATHE News Today GRCE News Today RANI News Today XFOR News Today PLUR News Today ANVS News Today GBIO News Today PEPG News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMRN) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMMURON Please log in to your account or sign up in order to add this asset to your watchlist. Share IMMURON With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMRN Stock Alerts